(Q38262676)

1 September 2017

1 reference

title

Glucokinase MODY and implications for treatment goals of common forms of diabetes (English)

1 reference

1 September 2017

Ramzi A Ajjan

1

1 reference

1 September 2017

Katharine R Owen

series ordinal

2

1 reference

1 September 2017

1 December 2014

1 reference

1 September 2017

Current diabetes report

1 reference

1 September 2017

14

1 reference

1 September 2017

12

1 reference

1 September 2017

559

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-014-0559-0

1 September 2017

0 references

cites work

Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Hypoglycemia and cardiovascular risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Linkage of type 2 diabetes to the glucokinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Diagnosis and management of maturity onset diabetes of the young (MODY).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

The genetic abnormality in the beta cell determines the response to an oral glucose load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

The pros and cons of diagnosing diabetes with A1C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Is there a glycemic threshold for mortality risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Card

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Post-prandial glucose and diabetic complications: systematic review of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Maturity-onset diabetes of the young (MODY): how many cases are we missing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0559-0

Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25344793

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Diabetes and survival after coronary artery bypass grafting: comparison with an age- and sex-matched population

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25344793

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11892-014-0559-0

1 reference

Dimensions Publication ID

1 September 2017

1020477849

0 references

Fatcat ID

release_koe2c2pom5evjbcxl4buuv2ywi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/koe2c2pom5evjbcxl4buuv2ywi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference